"10.1371_journal.pone.0018577","plos one","2011-04-07T00:00:00Z","Brigitte M Krenn; Andrej Egorov; Ekaterina Romanovskaya-Romanko; Markus Wolschek; Sabine Nakowitsch; Tanja Ruthsatz; Bettina Kiefmann; Alexander Morokutti; Johannes Humer; Janina Geiler; Jindrich Cinatl; Martin Michaelis; Nina Wressnigg; Sanda Sturlan; Boris Ferko; Oleg V Batishchev; Andrey V Indenbom; Rong Zhu; Markus Kastner; Peter Hinterdorfer; Oleg Kiselev; Thomas Muster; Julia Romanova","Avir Green Hills Biotechnology AG, Vienna, Austria; Influenza Research Institute, Russian Academy of Medical Sciences, St. Petersburg, Russia; A.N. Frumkin Institute of Physical Chemistry and Electrochemistry of Russian Academy of Sciences (RAS), Moscow, Russia; Christian Doppler Laboratory of Nanoscopic Methods in Biophysics, Institute for Biophysics, Johannes Kepler University Linz, Linz, Austria; Institute for Medical Virology, Johann Wolfgang Goethe University, Frankfurt, Germany","Conceived and designed the experiments: BMK AE MW SN RZ PH OK TM JC MM JR. Performed the experiments: BMK ER TR BK AM NW SS BF OB AI MK JH JG. Analyzed the data: BMK AE RZ PH TM JR. Contributed reagents/materials/analysis tools: ER TR SS RZ PH. Wrote the paper: BMK AE JR OB AI.","AVIR Green Hills Biotechnology (AGHB) is a privately held biopharmaceutical company based in Vienna (Austria) that draws on its own knowledge in virology to develop and commercialize an intranasal live attenuated vaccine targeting pandemic influenza disease among other products in the pipeline. BMK, AE, MW, SN, TR, BK, AM, NW, SS, BF, JH, TM, and RJ were employees of AGHB at the time of study. IPR rights related to this manuscript are covered by the following IP rights: DelNs1 mutants are covered by patents from AGHB and Mount Sinai School of Medicine. Patent applications covering the technology platform of the influenza virus and virus amplification procedure are fully owned by AGHB. In adherence to the PLoS guidelines, AGHB will make freely available any materials and information described in the publication that are reasonably requested by others for the purpose of academic, non-commercial research.","2011","04","Brigitte M Krenn","BMK",23,TRUE,11,13,6,5,TRUE,TRUE,FALSE,0,NA,FALSE
